Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer

✍ Scribed by Hyo-Pyo Lee; Sang-Soo Seo; Sang-Young Ryu; Jong-Hyeok Kim; Yung-Jue Bang; Sang-Yoon Park; Joo-Hyun Nam; Soon-Beom Kang; Kyung-Hee Lee; Yong Sang Song

• Book ID: 113961441
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 135 KB
• Volume: 109
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2007.11.023